Universal Ibogaine Inc (IBO) - Total Assets
Based on the latest financial reports, Universal Ibogaine Inc (IBO) holds total assets worth CA$4.01 Million CAD (≈ $2.90 Million USD) as of April 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See IBO total equity for net asset value and shareholders' equity analysis.
Universal Ibogaine Inc - Total Assets Trend (2018–2024)
This chart illustrates how Universal Ibogaine Inc's total assets have evolved over time, based on quarterly financial data.
Universal Ibogaine Inc - Asset Composition Analysis
Current Asset Composition (July 2024)
Universal Ibogaine Inc's total assets of CA$4.01 Million consist of 23.1% current assets and 76.9% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 8.2% |
| Accounts Receivable | CA$0.00 | 0.0% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Universal Ibogaine Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Universal Ibogaine Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Universal Ibogaine Inc's current assets represent 23.1% of total assets in 2024, a decrease from 100.0% in 2018.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, down from 16.2% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Universal Ibogaine Inc Competitors by Total Assets
Key competitors of Universal Ibogaine Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Argen-X
F:1AE
|
Germany | €7.18 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229
|
China | CN¥3.06 Billion |
|
R&G PharmaStudies Co. Ltd. A
SHE:301333
|
China | CN¥2.31 Billion |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
|
China | CN¥819.45 Million |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
China | CN¥2.16 Billion |
Universal Ibogaine Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.39 | 0.65 | 0.42 |
| Quick Ratio | 0.39 | 0.65 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-1.23 Million | CA$-395.19K | CA$-607.03K |
Universal Ibogaine Inc - Advanced Valuation Insights
This section examines the relationship between Universal Ibogaine Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.75 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | -18.0% |
| Total Assets | CA$4.51 Million |
| Market Capitalization | $1.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values Universal Ibogaine Inc's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Universal Ibogaine Inc's assets decreased by 18.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Universal Ibogaine Inc (2018–2024)
The table below shows the annual total assets of Universal Ibogaine Inc from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-07-31 | CA$4.51 Million ≈ $3.26 Million |
-17.97% |
| 2023-07-31 | CA$5.50 Million ≈ $3.98 Million |
-12.91% |
| 2022-07-31 | CA$6.32 Million ≈ $4.57 Million |
+187.31% |
| 2021-07-31 | CA$2.20 Million ≈ $1.59 Million |
+1785.57% |
| 2020-07-31 | CA$116.61K ≈ $84.36K |
-46.31% |
| 2019-07-31 | CA$217.21K ≈ $157.12K |
-32.26% |
| 2018-07-31 | CA$320.66K ≈ $231.96K |
-- |
About Universal Ibogaine Inc
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.